ATE241382T1 - Verwendung von lactoferrin zur prävention des nachoperativen astigmatismus - Google Patents

Verwendung von lactoferrin zur prävention des nachoperativen astigmatismus

Info

Publication number
ATE241382T1
ATE241382T1 AT96910225T AT96910225T ATE241382T1 AT E241382 T1 ATE241382 T1 AT E241382T1 AT 96910225 T AT96910225 T AT 96910225T AT 96910225 T AT96910225 T AT 96910225T AT E241382 T1 ATE241382 T1 AT E241382T1
Authority
AT
Austria
Prior art keywords
lactoferrin
prevention
post
operative astigmatism
astigmatism
Prior art date
Application number
AT96910225T
Other languages
English (en)
Inventor
Mitsushi Hikida
Masaaki Hayashi
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE241382T1 publication Critical patent/ATE241382T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96910225T 1995-05-08 1996-04-23 Verwendung von lactoferrin zur prävention des nachoperativen astigmatismus ATE241382T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP07109239A JP3118584B2 (ja) 1995-05-08 1995-05-08 術後乱視予防剤
PCT/JP1996/001092 WO1996035448A1 (fr) 1995-05-08 1996-04-23 Agent de traitement prophylactique de l'astigatisme postoperatoire

Publications (1)

Publication Number Publication Date
ATE241382T1 true ATE241382T1 (de) 2003-06-15

Family

ID=14505148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96910225T ATE241382T1 (de) 1995-05-08 1996-04-23 Verwendung von lactoferrin zur prävention des nachoperativen astigmatismus

Country Status (8)

Country Link
US (1) US6645936B1 (de)
EP (1) EP0826373B1 (de)
JP (1) JP3118584B2 (de)
AT (1) ATE241382T1 (de)
DE (1) DE69628430T2 (de)
DK (1) DK0826373T3 (de)
ES (1) ES2194983T3 (de)
WO (1) WO1996035448A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1149698A (ja) 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd 安定性を向上させたラクトフェリンの水性製剤
EP1284143A1 (de) * 2001-08-17 2003-02-19 Sifi S.p.A Verfahren zur Herstellung von pharmazeutischen Lactoferrin enthaltenden Formulierungen
US20070059300A1 (en) * 2005-09-12 2007-03-15 Zoltan Laboratories Llc Compounds and compositions to control abnormal cell growth
WO2007055760A2 (en) * 2005-10-31 2007-05-18 Essential Skincare, Llc Protein composition for promoting wound healing and skin regeneration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460135A1 (fr) * 1979-07-02 1981-01-23 Liotet Serge Composition a usage externe a base de colostrum
JPH0248534A (ja) 1988-07-28 1990-02-19 Bio Serae Sa:Soc 抗菌組成物の配合方法及び配合された抗菌組成物
DK0579830T3 (da) * 1990-11-13 1997-08-18 Santen Pharmaceutical Co Ltd Terapeutisk middel til hornhindebeskadigelse
JP3812957B2 (ja) * 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤

Also Published As

Publication number Publication date
EP0826373B1 (de) 2003-05-28
US6645936B1 (en) 2003-11-11
JPH08301785A (ja) 1996-11-19
EP0826373A1 (de) 1998-03-04
EP0826373A4 (de) 2000-06-14
JP3118584B2 (ja) 2000-12-18
ES2194983T3 (es) 2003-12-01
DE69628430T2 (de) 2004-05-19
DE69628430D1 (de) 2003-07-03
WO1996035448A1 (fr) 1996-11-14
DK0826373T3 (da) 2003-09-29

Similar Documents

Publication Publication Date Title
DE69324120D1 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
DE69422450D1 (de) Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
ATE179892T1 (de) Verwendung von lipid-gebundener glykoaminoglykanen zur behandlung der rheumatoider arthritis
ATE230757T1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE69232323D1 (de) Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
AU667593B2 (en) Inhibitors of HIV protease useful for the treatment of AIDS
DE69429299D1 (de) Verwendung von Tachykinin-Antagonisten zur Behandlung von Erbrechen
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE69231955D1 (de) Verwendung von N-(2,6-Dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamid zur Behandlung von Demenz
ATE302613T1 (de) Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids
ATE295183T1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
DE69628430D1 (de) Verwendung von lactoferrin zur prävention des nachoperativen astigmatismus
ATE148109T1 (de) Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
ATE193450T1 (de) Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von knochenbrüchen
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
ATE232739T1 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
ATE209005T1 (de) Verwendung von threonin zur behandlung der phenylketonurie
DE69113773D1 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
DE69932434D1 (de) Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0826373

Country of ref document: EP

REN Ceased due to non-payment of the annual fee